Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The renin-angiotensin system (RAS), also known as the renin-angiotensin-aldosterone system (RAAS), is a critical hormone cascade that regulates blood pressure, fluid balance, and electrolyte homeostasis in the body. It involves a series of hormones, enzymes, and receptors that act together to maintain cardiovascular stability. Overactivity or dysregulation of this system can lead to hypertension, heart failure, chronic kidney disease, and contribute significantly to cardiovascular morbidity. Pharmacologic agents targeting various steps—such as ACE inhibitors, ARBs (angiotensin receptor blockers), direct renin inhibitors—are widely used therapeutically for these conditions.
Inhibition of renin, ACE, or angiotensin receptors to reduce vasoconstriction, sodium retention, and water retention.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renin-Angiotensin System (RAS/RAAS).